A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Tadalafil N-Dipropyl Impurity | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Grades: > 95%. Molecular formula: C28H33N3O5. Mole weight: 491.59. |  |
| Tadalafil Oxo Impurity | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Synonyms: (6R,12aR)-6-(2-Oxo-1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione; 2'-Keto Tadalafil. Grades: > 95%. CAS No. 1346602-17-2. Molecular formula: C22H17N3O5. Mole weight: 403.40. | |
| Tadalafil Related Compound 1 | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Grades: > 95%. Molecular formula: C26H29N3O5. Mole weight: 463.54. | |
| Tadalafil Related Compound 2 | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Grades: > 95%. Molecular formula: C24H25N3O5. Mole weight: 435.48. | |
| Tadalafil Related Compound 3 | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Grades: > 95%. Molecular formula: C27H29N3O4. Mole weight: 459.55. | |
| Tadalafil Related Compound 4 | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Grades: > 95%. Molecular formula: C27H29N3O4. Mole weight: 459.55. | |
| Tadalafil Related Impuirty 5 | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Synonyms: (1R,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester. Grades: > 95%. CAS No. 171596-44-4. Molecular formula: C20H18N2O4. Mole weight: 350.38. | |
| Tadalafil Related Impuirty 6 | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Synonyms: (1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester. Grades: > 95%. CAS No. 171596-43-3. Molecular formula: C20H18N2O4. Mole weight: 350.38. | |
| Tadalafil Related Impurity 1 | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Grades: > 95%. Molecular formula: C26H25N3O4. Mole weight: 443.51. | |
| Tadalafil Spiro-2-keto-1,3-oxazine | Tadalafil Spiro-2-keto-1,3-oxazine. Group: Biochemicals. Alternative Names: Tadalafil Impurity. Grades: Highly Purified. Pack Sizes: 2.5mg. Molecular Formula: C22H19N3O6, Molecular Weight: 421.4. US Biological Life Sciences. |  Worldwide |
| Tadalafil Spiro-oxindole | Tadalafil Spiro-oxindole. Group: Biochemicals. Alternative Names: Tadalafil Impurity. Grades: Highly Purified. Pack Sizes: 2.5mg. Molecular Formula: C22H19N3O5, Molecular Weight: 405.4. US Biological Life Sciences. | Worldwide |
| Tadalafil Spiro-oxindole Impurity (EP Impurity I) | | |
| Tadalafil Spiro-urethane Impurity (EP Impurity F) | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatmen of erectile dysfunction. Synonyms: Tadalafil EP Impurity F; (8a'R)-6'-(1,3-Benzodioxol-5-yl)-2'-methyl-2',3',8',8a'-tetrahydro-6'H-spiro[3,1-benzoxazine-4,7'-pyrrolo[1,2a]pyrazine]-1',2,4'(1H)-trione. Grades: > 95%. Molecular formula: C22H19N3O6. Mole weight: 421.41. | |
| Tadjakonine | Heterocyclic Organic Compound. CAS No. 11087-94-8. Molecular formula: C31H35NO7. Mole weight: 533.62 Da. Purity: 97 % (TLC, NMR, mass spectrometry). Catalog: ACM11087948. |  |
| TA DNA Polymerase | TA DNA Polymerase. Ta dna polymerase is a mixture of taq dna polymerase with a proofreading 3-5 exonuclease. the fidelity is equal to hifi pfu dna polymerase. the yield is equal to that from taq dna polymerase. it is more suitable for high fidelity ta cloning. ta dna polymerase offers 18-fold fidelity as compared to taq dna polymerase. extension rate is about 1-2 kb/min. template-independentacan be generated at the 3end of the pcr product. amplification of genomic dna fragment up to 8 kb. Group: Cloning Enzymes. Purity: 250U; 500U. Storage: Store at -20 ?. Cat No: CE-3024. |  |
| tadocizumab | Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. Group: Inhibitors. Alternative Names: tadocizumab. CAS No. 339086-80-5. Purity: 0.96. Catalog: ACM339086805. | |
| TAE-1 | TAE-1 is an inhibitor of amyloid-β fibril formation and aggregation, suggesting its potential for the treatment of Alzheimer's disease. Synonyms: 2-[4-[[4, 6-bis[4-[2- (trimethylazaniumyl) ethoxycarbonyl]phenoxy]-1, 3, 5-triazin-2-yl]oxy]benzoyl]oxyethyl-trimethylazanium triiodide. CAS No. 1414469-59-2. Molecular formula: C39H51N6O9·3I. Mole weight: 1128.6. | |
| TAE226 | TAE226 is a novel and potent ATP competitive inhibitor of FAK and IGF-IR with potential anticancer activity. TAE226 can block FAK and IGF-IR signaling pathways. TAE226 inhibited the phosphorylation of FAK as well as the downstream effectors AKT, extracellular signal-related kinase, and S6 ribosomal protein in multiple glioma cell lines. TAE226 also decreased glioma cell adhesion, migration, and invasion through an artificial extracellular matrix. Synonyms: NVPTAE226, NVP TAE226, NVP-TAE226, TAE226, TAE226, TAE 226. Grades: 0.98. CAS No. 761437-28-9. Molecular formula: C23H25ClN6O3. Mole weight: 468.942. | |
| TAE684 | NVP-TAE684 is a highly potent and selective small-molecule ALK inhibitor, which blocked the growth of ALCL-derived and ALK-dependent cell lines with IC(50) values between 2 and 10 nM. NVP-TAE684 treatment resulted in a rapid and sustained inhibition of phosphorylation of NPM-ALK and its downstream effectors and subsequent induction of apoptosis and cell cycle arrest. In vivo, NVP-TAE684 suppressed lymphomagenesis in two independent models of ALK-positive ALCL and induced regression of established Karpas-299 lymphomas. NVP-TAE684 also induced down-regulation of CD30 expression, suggesting that CD30 may be used as a biomarker of therapeutic NPM-ALK kinase activity inhibition. Synonyms: TAE 684, TAE684, TAE-684, NVP-TAE 684, NVP-TAE684, NVP-TAE-684. CAS No. 761439-42-3. Molecular formula: C30H40ClN7O3S. Mole weight: 614.2017. | |
| TAE 684 | TAE 684. Group: Biochemicals. Alternative Names: NVP-TAE 684; NVT TAE-684; 5-Chloro-N2-[2-methoxy-4-[4- (4-methyl-1-piperazinyl) -1-piperidinyl]phenyl]-N4-[2-[ (1-methylethyl) sulfonyl]phenyl]-2, 4-pyrimidinediamine. Grades: Highly Purified. CAS No. 761439-42-3. Pack Sizes: 10mg. Molecular Formula: C30H40ClN7O3S, Molecular Weight: 614.2. US Biological Life Sciences. | Worldwide |
| TAE buffer (50X) | 1lt Pack Size. Group: Biochemicals, Buffers. Formula: N/A. Prepack ID 12439469-1lt. See USA prepack pricing. |  |
| Tafamidis | Tafamidis is a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. It is a drug for the amelioration of transthyretin-related hereditary amyloidosis. It functions by kinetic stabilization of the correctly folded tetrameric form of the transthyretin (TTR) protein and binds selectively and with negative cooperativity to the two normally unoccupied thyroxine-binding sites of the tetramer, and kinetically stabilizes TTR. Synonyms: Fx-1006A; Vyndaqel. Grades: >98%. CAS No. 594839-88-0. Molecular formula: C14H7Cl2NO3. Mole weight: 308.12. | |
| Tafamidis | Tafamidis is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC 50 s of 2.7-3.2 μM. Tafamidis inhibits amyloidogenesis [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 594839-88-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-14852. |  |
| Tafamidis meglumine | Tafamidis meglumine (Fx-1006A) is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC 50 s of 2.7-3.2 μM. Tafamidis meglumine inhibits amyloidogenesis [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Fx-1006A. CAS No. 951395-08-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-14852A. | |
| Tafasitamab | Tafasitamab is a humanized FC-modified monoclonal antibody that binds to CD19, which is broadly expressed on the surface of B cells. Tafasitamab is indicated for the treatment of B cell malignancies, such as non-Hodgkin's lymphoma (NHL), including diffuse large B cell lymphoma (DLBCL), indolent lymphomas like follicular lymphoma (FL) and marginal zone lymphomas (MZL), as well as chronic lymphocytic leukemia (CLL). Synonyms: XmAb5574; MOR00208; MOR208; Tafasitamab-cxix. CAS No. 1422527-84-1. | |
| Tafasitamab | Tafasitamab (XmAb5574) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19 [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: XmAb5574; MOR00208; Tafasitamab-cxix. CAS No. 1422527-84-1. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P9981. | |
| Tafenoquine | Tafenoquine (WR 238605) is an 8-aminoquinoline. Tafenoquine is an anti-malarial prophylactic agent [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: WR 238605. CAS No. 106635-80-7. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-111529. | |
| Tafenoquine | Tafenoquine is an oral active and an 8-aminoquinoline antimalaria drug. It is being investigated as a potential treatment for malaria, as well as for malaria prevention.It is for treatment of the hypnozoite stages of Plasmodium vivax and Plasmodium ovale that are responsible for relapse of these malaria species even when the blood stages are successfully cleared. It targets leishmania respiratory complex III and induces apoptosis. It has a long half-life of approximately 14 days and is generally safe and well tolerated, thus therefore a single treatment may be sufficient to clear hypnozoites. It was manufactured by GlaxoSmithKline and in clinic phase 3 trials. Uses: Tafenoquine is being investigated as a potential treatment for malaria, as well as for malaria prevention.it is for treatment of the hypnozoite stages of plasmodium vivax and plasmodium ovale. Synonyms: 4-[5-[3-(Trifluoromethyl)phenoxy]-2, 6-dimethoxy-4-methyl-8-quinolinylamino]-1-pentanamine; 8-[(4-Amino-1-methylbutyl)amino]-2, 6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinoline; N4-(2, 6-diMethoxy-4-Methyl-5-(3-(trifluoroMethyl)phenoxy)quinolin-8-yl)pentane-1, 4-diamine; WR-238605; WR238605; Etaquine. Grades: >98%. CAS No. 106635-80-7. Molecular formula: C24H28F3N3O3. Mole weight: 463.50. | |
| Tafenoquine Succinate | Tafenoquine is a medication for the prevention and treatment of malaria. Synonyms: WR 238605; WR-238605; WR238605. CAS No. 106635-81-8. Molecular formula: C28H34F3N3O7. Mole weight: 581.6. | |
| Tafenoquine Succinate | Tafenoquine Succinate (WR 238605 Succinate) is an 8-aminoquinoline. Tafenoquine is an anti-malarial prophylactic agent [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: WR 238605 Succinate. CAS No. 106635-81-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-111529A. | |
| Tafetinib | Tafetinib (SIM010603) is an oral multi-targets receptor tyrosine kinases inhibitor. Tafetinib inhibits stem cell factor receptor (Kit) , vascular endothelial growth factor receptor-2 (VEGFR-2) , platelet-derived growth factor receptor-β (PDGFR-β) , glial cell line-derived neurotrophic factor receptor (Rearranged during Transfection; RET) , and Fms-like tyrosine kinase-3 (FLT3) with IC 50 values between 5.0 and 68.1 nmol/l. Tafetinib inhibits the phosphorylation of PDGFR-β and VEGFR-2. Tafetinib inhibits endothelial cell proliferation, endothelial cells chemotaxis, and corneal angiogenesis [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: SIM010603. CAS No. 1032265-57-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-116116. | |
| Tafluprost | Tafluprost. Group: Biochemicals. Alternative Names: (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic Acid 1-Methylmethyl Ester; AFP 168; MK 2452; Taflotan; Tapros. Grades: Highly Purified. CAS No. 209860-87-7. Pack Sizes: 2.5mg. Molecular Formula: C25H34F2O5, Molecular Weight: 452.53. US Biological Life Sciences. | Worldwide |
| Tafluprost | Tafluprost (AFP-168) is an anti-glaucoma prostaglandin (PG) analog. Tafluprost can inhibit the apoptosis of retinal ganglion cells (RGCs) and rat RGCs cells. Tafluprost promotes axon regeneration by regulating Zn 2+ - mTOR pathway, inhibits intracellular lipid accumulation in human preorbital adipocytes. Tafluprost can be used in the study of optic nerve injury in glaucoma [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: AFP-168; MK2452. CAS No. 209860-87-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-B0600. | |
| Tafluprost | Tafluprost is a novel prostanoid analogue that activates Prostaglandin Receptor. It is used in the treatment of glaucoma and is the first prostanoid to be released in a preservative free-formula. Synonyms: AFP-168, AFP-168, AFP-168, MK-2452, MK2452, MK 2452, Taflotan; Zioptan; AFP-168; Saflutan; propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate. Grades: ≥ 98%. CAS No. 209860-87-7. Molecular formula: C25H34F2O5. Mole weight: 452.539. | |
| Tafluprost acid | Tafluprost acid (AFP-172), an active metabolic form of Tafluprost, is a selective prostanoid FP receptor agonist. Tafluprost acid shows a high affinity for human prostanoid FP receptor with K i and EC 50 values of 0.4 nM and 0.53 nM, respectively. Tafluprost acid has 126 times weaker binding affinity for prostanoid EP3 receptor ( IC 50 =67 nM) than for the prostanoid FP receptor. Tafluprost acid can be used in the research of glaucoma [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: AFP-172. CAS No. 209860-88-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-B0601. | |
| Tafluprost acid | Synonyms: (Z)-7-[(1R,2R,3R,5S)-2-((E)-3,3-Difluoro-4-phenoxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl]hept-5-enoic Acid; 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-butenyl]-3,5-dihydroxycyclopentyl]-5-Heptenoic Acid; AFP 172. Grades: > 95%. CAS No. 209860-88-8. Molecular formula: C22H28F2O5. Mole weight: 410.46. | |
| Tafluprost-d7 | Tafluprost-d7. Group: Biochemicals. Alternative Names: (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic Acid 1-Methylmethyl Ester-d7; AFP 168-d7; MK 2452-d7; Taflotan-d7; Tapros-d7. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C25H27D7F2O5, Molecular Weight: 459.57. US Biological Life Sciences. | Worldwide |
| Tafluprost ethyl amide | Synonyms: Taflpostamide; (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]-N-ethylhept-5-enamide. CAS No. 1185851-52-8. Molecular formula: C24H33F2NO4. Mole weight: 437.5. | |
| Tafluprost ethyl ester | Tafluprost ethyl ester is an analog of prostaglandin F2α (PGF2α), which has been approved for the treatment of glaucoma. Synonyms: AFP 175; Ethyl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate. Grades: ≥98%. CAS No. 209860-89-9. Molecular formula: C24H32F2O5. Mole weight: 438.5. | |
| Tafluprost Impurity 10 | Tafluprost Impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 40665-68-7. Molecular Formula: C11H15O5P. Mole Weight: 258.21. Catalog: APB40665687. |  |
| Tafluprost Impurity 11 | Tafluprost Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 39746-00-4. Molecular Formula: C15H16O5. Mole Weight: 276.29. Catalog: APB39746004. | |
| Tafluprost Impurity 19 | Tafluprost Impurity 19. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2587078-46-2. Molecular Formula: C25H35FO5. Mole Weight: 434.55. Catalog: APB2587078462. | |
| Tafluprost Impurity 22 | Tafluprost Impurity 22. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2587078-47-3. Molecular Formula: C25H34F2O5. Mole Weight: 452.54. Catalog: APB2587078473. | |
| Tafluprost Impurity 7 | Tafluprost Impurity 7. Uses: For analytical and research use. Group: Impurity standards. CAS No. 733036-94-7. Molecular Formula: C25H35FO5. Mole Weight: 434.55. Catalog: APB733036947. | |
| Tafluprost Impurity 8 | Tafluprost Impurity 8. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2278245-92-2. Molecular Formula: C27H41BrO5. Mole Weight: 525.52. Catalog: APB2278245922. | |
| Tafluprost Impurity 9 | Tafluprost Impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2099033-66-4. Molecular Formula: C27H41NO8. Mole Weight: 507.62. Catalog: APB2099033664. | |
| Tafluprost Impurity DCP-1 | Tafluprost Impurity DCP-1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 209860-88-8. Molecular Formula: C22H28F2O5. Mole Weight: 410.46. Catalog: APB209860888. | |
| Tafluprost Impurity DCP-2 | Tafluprost Impurity DCP-2. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1563176-58-8. Molecular Formula: C25H34F2O5. Mole Weight: 452.54. Catalog: APB1563176588. | |
| Tafolecimab | Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: IBI-306. CAS No. 2225109-03-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99552. | |
| TAG-1 A2 (78-86) | | |
| TAG-2 (42-50) | | |
| Tagatose | Tagatose is a white, anhydrous crystalline solid. It is a carbohydrate, a ketohexose, an epimer of D-fructose inverted at C-4. It can exist in several tautomeric forms. Synonyms: D-lyxo-Hexulose; (3S, 4S, 5R)-2-(hydroxymethyl)oxane-2, 3, 4, 5- tetrol; Naturlose; D-tagatose; tagatosum; tagatoza. CAS No. 87-81-0. Product ID: PE-0495. Molecular formula: C6H12O6. Mole weight: 180.16. Category: Sweetening agent. Product Keywords: Pharmaceutical Excipients; Excipients for Solid Dosage Form; Tagatose; Sweeteners Excipients; Sweetening agent; C6H12O6; 87-81-0; 87-81-0. UNII: T7A20Y888Y. Chemical Name: (3S, 4S, 5R)-1, 3, 4, 5, 6-pentahydroxyhexan-2-one. Administration route: oral and rectal. Dosage Form: oral and rectal solutions. Stability and Storage Conditions: Tagatose is stable under pH conditions typically encountered in foods (pH > 3). It is a reducing sugar and undergoes the Maillard reaction. Tagatose is stable under typical storage conditions. It caramelizes at elevated temperature. Source and Preparation: Tagatose is obtained from D-galactose by isomerization under alkaline conditions in the presence of calcium. Applications: Tagatose is used as a sweetening agent in beverages, foods, and pharmaceutical applications. A 10% solution of tagatose is about 92% as sweet as a 10% sucrose solution.It is a low-calorie sugar with approximately 38% of the calories of sucrose per gram. It occurs naturally in low levels in milk pro |  |
| tagatose-6-phosphate kinase | This enzyme belongs to the family of transferases, specifically those transferring phosphorus-containing groups (phosphotransferases) with an alcohol group as acceptor. The systematic name of this enzyme class is ATP:D-tagatose-6-phosphate 1-phosphotransferase. This enzyme participates in galactose metabolism. Group: Enzymes. Enzyme Commission Number: EC 2.7.1.144. CAS No. 39434-00-9. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2974; tagatose-6-phosphate kinase; EC 2.7.1.144; 39434-00-9. Cat No: EXWM-2974. | |
| tagatose-bisphosphate aldolase | Enzyme activity is stimulated by certain divalent cations. It is involved in the tagatose 6-phosphate pathway of lactose catabolism in bacteria. Group: Enzymes. Synonyms: D-tagatose-1,6-bisphosphate triosephosphate lyase. Enzyme Commission Number: EC 4.1.2.40. CAS No. 39433-95-9. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4876; tagatose-bisphosphate aldolase; EC 4.1.2.40; 39433-95-9; D-tagatose-1,6-bisphosphate triosephosphate lyase. Cat No: EXWM-4876. | |
| tagatose kinase | This enzyme belongs to the family of transferases, specifically those transferring phosphorus-containing groups (phosphotransferases) with an alcohol group as acceptor. This enzyme participates in galactose metabolism. Group: Enzymes. Enzyme Commission Number: EC 2.7.1.101. CAS No. 39434-00-9. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2948; tagatose kinase; EC 2.7.1.101; 39434-00-9. Cat No: EXWM-2948. | |
| tagaturonate reductase | This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is D-altronate:NAD+ 3-oxidoreductase. Other names in common use include altronic oxidoreductase, altronate oxidoreductase, TagUAR, altronate dehydrogenase, and D-tagaturonate reductase. This enzyme participates in pentose and glucuronate interconversions. Group: Enzymes. Synonyms: altronic oxidoreductase; altronate oxidoreductase; TagUAR; altronate dehydrogenase; D-tagaturonate reductase. Enzyme Commission Number: EC 1.1.1.58. CAS No. 9028-45-9. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-0343; tagaturonate reductase; EC 1.1.1.58; 9028-45-9; altronic oxidoreductase; altronate oxidoreductase; TagUAR; altronate dehydrogenase; D-tagaturonate reductase. Cat No: EXWM-0343. | |
| Tagette Oil | Tagette Oil. CAS No. 8016-84-0. FEMA No. 3040. Kosher: Y. VIGON Item # 504279. Categories: Speciality Ingrdients Suppliers, Flavors, Fragrances, Perfumers, Aromatherapy, Essetial Oils. |  America & Internationally |
| Tagitanlimab | Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic nasopharyngeal carcinoma (NPC) [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: HBM-9167; KL-A167. CAS No. 2417649-97-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99544. | |
| TAI-1 | TAI-1 disrupts the binding of Nek2 to Hec1, which leads to degradation of Nek2 and chromosomal misalignment. Synonyms: TAI-1; TAI1; TAI 1. Grades: >98%. CAS No. 1334921-03-7. Molecular formula: C24H21N3O3S. Mole weight: 431.51. | |
| TAICATOXIN | Heterocyclic Organic Compound. Alternative Names: TCX;TAICATOXIN;taicatoxin from oxyuranus s. scutellatus (taipan snake) venom. CAS No. 112154-17-3. Catalog: ACM112154173. | |
| TAIKh 211 (9CI) | Heterocyclic Organic Compound. CAS No. 113610-04-1. Catalog: ACM113610041. | |
| Taipehensin-B1 antimicrobial peptide precursor | Taipehensin-B1 antimicrobial peptide precursor is an antibacterial peptide isolated from Hylarana taipehensis. Synonyms: Thr-Met-Lys-Lys-Leu-Leu-Leu-Leu-Phe-Phe-Phe-Leu-Gly-Thr-Ile-Ser-Ser-Ser-Leu-Cys-Glu-Lys-Glu-Arg-Asp-Ala-Asp-Glu-Asp-Glu-Val-Asn-Arg-Gly-Glu-Ala. Grades: >98%. | |
| TAK-044 | Tak-044 has been found to be an endothelin receptor antagonist that was once studied against some sort of liver disorders and subarachnoid haemorrhage. Synonyms: TAK-044, TAK 044, TAK044; CHEMBL61425; AC1L3XH4; Cyclo(D-alpha-aspartyl-3-((4-phenylpiperazin-1-yl)carbonyl)-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl)glycyl-L-leucyl-D-tryptophyl) disodium salt; AM017317. Grades: 98%. CAS No. 157380-72-8. Molecular formula: C45H51N9Na2O11S. Mole weight: 971.99. | |
| TAK-063 | TAK-063 is a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor. TAK-063 is currently being evaluated in clinical trials for the treatment of schizophrenia. Phosphodiesterase 10A (PDE10A) is a cAMP/cGMP phosphodiesterase highly expressed in medium spiny neurons (MSNs) in the striatum. TAK-063 represents a promising drug for the treatment of schizophrenia with potential for superior safety and tolerability profiles. Synonyms: TAK063, TAK 063, TAK-063, Balipodect. Grades: >98%. CAS No. 1238697-26-1. Molecular formula: C23H17FN6O2. Mole weight: 428.42. | |
| TAK-070 | TAK-070, under the IUPAC name 2-Naphthaleneethanamin?e, 6-([1,?1'-biphenyl]?-4-ylmethoxy)?-1,?2,?3,?4-tetrahydro-N,?N-dimethyl-, hydrochloride, hydrate (1:1:1)?, (2R)?-, a novel noncompetitive BACE1 inhibitor, ameliorated Aβ pathology and behavioral deficits in Tg2576. Phase 1. Synonyms: TAK-070; TAK 070; TAK070; 2-Naphthaleneethanamin?e, 6-([1,?1'-biphenyl]?-4-ylmethoxy)?-1,?2,?3,?4-tetrahydro-N,?N-dimethyl-, hydrochloride, hydrate (1:1:1)?, (2R)?-; 2-Naphthaleneethanamine, 6-([1,1'-biphenyl]-4-ylmethoxy)-1,2,3,4-tetrahydro-N,N-dimethyl-, hydrochloride, monohydrate, (2R)- (9CI); UNII-EAC604ZY07; 365276-12-6. CAS No. 365276-12-6. Molecular formula: C27H31NO.HCl.H2O. Mole weight: 440.02. | |
| TAK-071 | TAK-071 is a positive allosteric modulator of muscarinic acetylcholine receptor 1 (M1R). Uses: Muscarinic agonists. Synonyms: TAK-071; 1820812-16-5; UNII-59XC9G796Y; 59XC9G796Y; 4-Fluoro-2-((3S, 4S)-4-hydroxytetrahydro-2H-pyran-3-yl)-5-methyl-6-(4(1H-pyrazol-1-yl)benzyl)-2, 3-dihydro-1H-isoindol-1-one; L-Threo-pentitol, 1,5-anhydro-2,4-dideoxy-2-(4-fluoro-1,3-dihydro-5-methyl-1-oxo-6-((4-(1H-pyrazol-1-yl)phenyl)methyl)-2H-isoindol-2-yl)-; 4-fluoro-2-[(3S,4S)-4-hydroxyoxan-3-yl]-5-methyl-6-[(4-pyrazol-1-ylphenyl)methyl]-3H-isoindol-1-one; 6-(4-(1H-PYRAZOL-1-YL)BENZYL)-4-FLUORO-2-((3S,4S)-4-HYDROXYTETRAHYDRO-2H-PYRAN-3-YL)-5-METHYLISOINDOLIN-1-ONE; CHEMBL4594351; SCHEMBL17201222; GTPL12302; WFSARWQASFQZMG-VXKWHMMOSA-N; AKOS040739717; AC-31580; MS-27399; HY-122190; CS-0082523; D77973; 1,5-anhydro-2,4-dideoxy-2-(4-fluoro-5-methyl-1-oxo-6-(4-(1H-pyrazol-1-yl)benzyl)-1,3-dihydro-2H-isoindol-2-yl)-L-threo-pentitol; 4-fluoro-2-[(3s,4s)-4-hydroxytetrahydro-2h-pyran-3-yl]-5-methyl-6-[4-(1h-pyrazol-1-yl)benzyl]-2,3-dihydro-1h-isoindol-1-one. Grades: 98%. CAS No. 1820812-16-5. Molecular formula: C24H24FN3O3. Mole weight: 421.5. | |
| TAK-071 | TAK-071 is a novel, potent and highly selective muscarinic acetylcholine receptor 1 (M1R) positive allosteric modulator. EC 50 of TAK-071 M1R agonist activities is 520 nM [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1820812-16-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-122190. | |
| TAK 165 | TAK 165. Group: Biochemicals. Grades: Purified. CAS No. 366017-09-6. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| TAK1-IN-3 | TAK1-IN-3 is a potent ATP-competitive TAK1 inhibitor. Uses: Scientific research. Group: Signaling pathways. CAS No. 494772-87-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-115743. | |
| TAK 21d | TAK 21d. Group: Biochemicals. Grades: Purified. CAS No. 1143578-94-2. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
